421 related articles for article (PubMed ID: 26935510)
1. The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.
Radomska A; Leszczyszyn J; Radomski MW
Adv Clin Exp Med; 2016; 25(1):151-62. PubMed ID: 26935510
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
[TBL] [Abstract][Full Text] [Related]
3. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
5. Quantum dots in nanomedicine: recent trends, advances and unresolved issues.
Volkov Y
Biochem Biophys Res Commun; 2015 Dec; 468(3):419-27. PubMed ID: 26168726
[TBL] [Abstract][Full Text] [Related]
6. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
[TBL] [Abstract][Full Text] [Related]
7. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
8. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
Fadeel B; Garcia-Bennett AE
Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterials for regenerative medicine.
Verma S; Domb AJ; Kumar N
Nanomedicine (Lond); 2011 Jan; 6(1):157-81. PubMed ID: 21182426
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Managing Atherosclerosis via Nanomedicine.
Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
Small; 2018 Jan; 14(4):. PubMed ID: 29239134
[TBL] [Abstract][Full Text] [Related]
11. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
[TBL] [Abstract][Full Text] [Related]
12. Application of nanomedicine in cardiovascular diseases and stroke.
Kim KS; Khang G; Lee D
Curr Pharm Des; 2011; 17(18):1825-33. PubMed ID: 21631424
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine: tiny particles and machines give huge gains.
Tong S; Fine EJ; Lin Y; Cradick TJ; Bao G
Ann Biomed Eng; 2014 Feb; 42(2):243-59. PubMed ID: 24297494
[TBL] [Abstract][Full Text] [Related]
14. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
15. [Nanoparticles: properties and application prospects].
Chekman IS
Ukr Biokhim Zh (1999); 2009; 81(1):122-9. PubMed ID: 19877425
[TBL] [Abstract][Full Text] [Related]
16. Emerging trends of nanomedicine--an overview.
Sandhiya S; Dkhar SA; Surendiran A
Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine and nanotoxicology: two sides of the same coin.
Kagan VE; Bayir H; Shvedova AA
Nanomedicine; 2005 Dec; 1(4):313-6. PubMed ID: 17292104
[TBL] [Abstract][Full Text] [Related]
18. Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
David CA; Owen A; Liptrott NJ
Nanomedicine (Lond); 2016 Jun; 11(11):1447-64. PubMed ID: 27171671
[TBL] [Abstract][Full Text] [Related]
19. Gold-Based Nanomaterials for Applications in Nanomedicine.
Ashraf S; Pelaz B; del Pino P; Carril M; Escudero A; Parak WJ; Soliman MG; Zhang Q; Carrillo-Carrion C
Top Curr Chem; 2016; 370():169-202. PubMed ID: 26589509
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles, nanotechnology and pulmonary nanotoxicology.
Ferreira AJ; Cemlyn-Jones J; Robalo Cordeiro C
Rev Port Pneumol; 2013; 19(1):28-37. PubMed ID: 23265236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
